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Objective: To determine the relationship between hippocampal atrophy (HA), neu-
rocysticercosis calcifications (NC) and seizure semiology in patients with partial
epilepsy.
Methods: We identified two groups of patients: mesial temporal lobe epilepsy (MTLE)
and extra-temporal epilepsy (ETE) patients. Each group was subdivided according to
CT findings: normal, NC in the temporal regions, and NC in extra-temporal regions.
MRI was obtained in a 2-Tscanner and hippocampal volumetry was performed using 3-
mm coronal T1-IR images. Hippocampal volumes below 2 standard deviations from the
mean of the control group determined the presence of HA.
Results: We studied 89 consecutive patients: 63 with MTLE and 26 with ETE. HA was
found in 43/89 (49.5 %) patients, 42 of them with MTLE. There was no difference in
frequency of HA in the comparison between patients with (25/50) andwithout NC (18/
39) (x2, p = 0.71). Furthermore, there was no relationship between localization of NC
(temporal or extra-temporal) and seizure semiology (MTLE or ETE).
Conclusions: HA was more frequent and more severe in patients with MTLE, with no
differences regarding the presence and localization of NC. These findings further
support the concept that NC on CT not necessarily indicate the etiology of epilepsy
and may represent only a co-existent pathology.
# 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Neurocysticercosis calcifications (NC) are consid-
ered as the main etiology of late-onset epilepsy in
developing countries.1—6 In Brazil, cysticercosis is an* Corresponding author. Tel.: +55 19 3788 7292;
fax: +55 19 3289 1818.
E-mail address: fcendes@unicamp.br (F. Cendes).
1059-1311/$ — see front matter # 2004 BEA Trading Ltd. Published
doi:10.1016/j.seizure.2004.10.005endemic disease and seizures are the most frequent
NC symptom occurring in up to 92% of patients.
However, there is no basis to confirm this associa-
tion, as the calcified granules may be an incidental
finding, and not necessarily the epileptogenic lesion.
The active and transitional forms of cysticercosis on
the other hand have an abrasive effect, causing an
inflammatory reactionwhich leads toadiscreteastro-
gliosis that seems to be epileptogenic.7by Elsevier Ltd. All rights reserved.
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relationship between hippocampal atrophy (HA),
neurocysticercosis calcifications (NC) and seizure
semiology in patients with partial epilepsy.Methods
Ethical aspects
All patients signed an informed consent prior to MRI
scanning, and this was approved by our medical
school Ethics Committee.
Patients
We prospectively selected patients from Campinas
State University Epilepsy Clinic who fulfilled the
following criteria:1. Clinical-EEG diagnosis of partial epilepsy accord-
ing to the ILAE recommendations,8,9 divided in
the following epilepsy syndromes:
 Mesial temporal lobe epilepsy (MTLE): recur-
rent simple partial seizures (SPS) with psychic or
autonomic symptomsorcomplexpartial seizures
(CPS) compatible with temporal lobe origin.
 Extra-temporal epilepsy (ETE): recurrent SPS
with motor manifestation, visual symptoms, or
other signs and symptoms indicating extra-
temporal seizure onset, with support of inter-
ictal EEG epileptiform discharges.
Patients with partial epilepsy who did not
complete the diagnostic investigation or who
had incomplete information about seizure semi-
ology were not included in this study.2. Available computed tomography (CT) scan,
which findings were classified according to the
following groups:
 No identifiable lesions
 NC in the temporal lobes
 NC outside the temporal regions3. Available high-resolution magnetic resonance
imaging (MRI), acquired according to our epi-
lepsy protocol (see MRI acquisition)
Investigation
All patients underwent routine electroencephalo-
gram recordings (EEG) in addition to CT and MRI
scan.1. Routine interictal EEG was acquired using a 16-
channel machine, with 10—20 system for elec-
trode placement, including anterior temporalelectrodes (T1/T2). We did not obtain ictal
recordings for this study.2. MRI acquisition was performed in a 2-T scanner
(Elscint Prestige1, Haifa, Israel), in three ortho-
gonal planes, and a volumetric sagital T1 acqui-
sition for multiplanar reconstruction.3. Hippocampal volumetric measurements were
performed according to anatomic guidelines
from a standard protocol10 in T1-IR 3-mm coronal
slices (flip angle = 2008; TR = 2800, TE = 14,
inversion time (TI) = 840, matrix 130  256,
FOV = 16 cm  18 cm). We performed manual
delineation of the entire extension of hippocam-
pal formation using NIH-Image program1 (devel-
oped at the United States National Institutes of
Health and available on the Internet at http://
www.rsb.info.nih.gov/nih-image/).
Hippocampal volumes (HcV) were corrected
for the variation in total intracranial volume, and
asymmetry index (HcAI) were determined for
each subject as the ratio of the smaller by the
larger hippocampus. Volumes were transformed
into Z scores: number of standard deviations
from the mean of control group (composed by
30 healthy adult volunteers). Z scores below
2.0 were indicative of atrophy.
The investigators who interpreted MRIs and
performed MRI volumetric measurements were
blinded to patients’ clinical and EEG information.4. Statistical analyses
We used SYSTAT91 for statistical analyses.
Patients were divided in the following groups:
Group 1: MTLE patients with NC in extra-tem-
poral regions
Group 2: MTLE patients without NC
Group 3: MTLE patients with NC in the temporal
regions
Group 4: ETE patients with NC in extra-temporal
regions
Group 5: ETE patients without NC
Group 6: ETE patients with NC in the temporal
regionsChi-square test (x2) or Fisher’s exact test were
performed to determine association of HA
according to the epilepsy syndromes and pre-




A total of 89 patients (62 women) were evaluated,
with a mean age of 36 years (ranging from 7 to 62),
and no difference between the six groups (p = 0.27).
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Table 1 Age at seizure onset and occurrence of feb-
rile seizures in early childhood in the different sub-
groups of patients.
Group N Earlier FS Seizure onset,
mean (S.D.)
MTLE (n = 63)
1 18 4 (22%) 9.3 (2—24)
2 25 5 (20%) 9 (0.7—36)
3 20 2 (10%) 10.4 (3—26)
ETE (n = 26)
4 7 0 14.8 (7—31)
5 14 3 (21.5%) 8.4 (1—17)
6 5 0 10.6 (6—26)
MTLE: mesial temporal lobe epilepsy; ETE: extra-temporal
epilepsy; HA: hippocampal atrophy; R: right; L: left; NC:
neurocysticercosis calcifications; FS: febrile seizures; seizure
onset: age at seizure onset in years. Group 1: MTLE patients
with NC in extra-temporal regions. Group 2: MTLE patients
without NC. Group 3: MTLE patients with NC in the temporal
regions. Group 4: ETE patients with NC in extra-temporal
regions. Group 5: ETE patients without NC. Group 6: ETE
patients with NC in the temporal regions.
Table 2 Relative frequency of hippocampal atrophy in
the different subgroups of patients.
Group Hippocampal atrophy
MTLE (n = 63)
1 9/18 (50%): R = 6, L = 3
2 18/25 (72%): R = 5, L = 13
3 15/20 (75%): R = 8, L = 7
ETE (n = 26)
4 0 (0%)
5 0 (0%)
6 1/5 (20%): R = 1a
MTLE: mesial temporal lobe epilepsy; ETE: extra-temporal
epilepsy; HA: hippocampal atrophy; R: right; L: left; NC:
neurocysticercosis calcifications; FS: febrile seizures; seizure
onset: age at seizure onset in years. Group 1: MTLE patients
with NC in extra-temporal regions. Group 2: MTLE patients
without NC. Group 3: MTLE patients with NC in the temporal
regions. Group 4: ETE patients with NC in extra-temporal
regions. Group 5: ETE patients without NC. Group 6: ETE
patients with NC in the temporal regions.
a Dual pathology (see text).Patients from group 1 had earlier seizure onset,
but this was not statistically significant (p = 0.44).
The presence of NC did not influence age at seizure
onset (p = 0.2), even though it occurred later in
patients with NC.
History of earlier febrile seizure was identified in
14 (15.4%) individuals, with no difference between
patients with MTLE (17.5%) and patients with ETE
(11.5%) (p = 0.48).
Medically refractory seizures were identified in
50/89 (56.7%) patients, and although more frequent
in patients with MTLE (39/63) than in patients with
ETE (11/26), this did not reach statistical signifi-
cance (p = 0.09). In addition, there was no differ-
ence in the proportion of patients with seizure
control with presence or absence of calcifications
(p = 0.96) (Table 1).
Hippocampal volumetry
There were 43/89 (48.5%) patients with HA: 20 with
right HA and 23 with left HA (for distribution among
different subgroups, please see Table 2).
HA was observed in 42/63 (66.6%) MTLE patients
and in only 1/26 (4%) ETE patients (p < 0.0001).
However, there was no difference in the frequency
of HA between patients with (25/50) and without NC
(18/39) (p = 0.7).
We did not find an association between the loca-
tion of NC (temporal or extra-temporal) and seizure
semiology (MTLE or ETE) (p = 0.5). On the other
hand, HA was more frequently found in MTLE
patients with NC (75%) than ETE patients with NC(20%) (p = 0.047). In patients with MTLE, we found
no differences in HcVs (p > 0.1) or frequency of HA
(p = 0.2) among subgroups.
Seizure control was worse in patients with HA
(32/43—74.5%) when compared to patients with
normal HcVs (18/46—39%) (p = 0.001). Patients with
refractory seizures had smaller right (p = 0.001) and
left (p = 0.024) HcVs. In addition, patients with
MTLE had more severe HA, determined by the HcAI
(p = 0.00001).
The only patient with ETE who had abnormal HcV
(right HA) was a 52 years old woman with simple
partial seizures since 11 years old (motor manifes-
tation in the left hemi-body with Jacksonian
march), complex partial seizures and secondarily
generalized tonic—clonic seizures. Her recent inter-
ictal EEGs were normal, she has multiple NC calci-
fications on CT scan (including the temporal
regions). From 17 to 21 years of age she had had
episodes of jamais-vu and fear, that did not recur
afterwards. She is also followed in the psychiatry
clinic for diagnosis of personality disorder and pos-
sible non-epileptic seizures. She is on medication
and seizure-free for 6 months now.Discussion
In this study, we quantified HcVs to investigate the
relationship among HA, seizure semiology and
the presence and localization of NC. HA was more
frequent and more severe in MTLE patients. In
addition, there was no relationship between the
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severity of HA, or with the seizure semiology.
There are different theories proposed for inter-
action between NC, hippocampal pathology and
seizures.5,11,12 The first possibility was that NC
would be the epileptogenic lesion, causing partial
seizures with semiology compatible with the loca-
lization of the calcifications (for example, NC in the
temporal regions causing seizures with temporal
lobe semiology). However, we did not observe such
relationship in our patients.
One other hypothesis was that HA could be
more frequent in the group of patients with
MTLE and the degree of HA, as well as the severity
of epilepsy, could be related to the presence of
additional NC lesion in the temporal structures.
Therefore, the presence of NC in the temporal
region, in patients with the syndrome of MTLE
would be associatedwithmore severe hippocampal
damage and worse seizure control. This takes
into account that seizures started due to the
hippocampal pathology, which worsens with the
presence of additional effects from an inflamma-
tory response. It is reported in the literature,
however, that the presence of HA in patients
with MTLE associates with a good post-operative
prognosis, and the co-existence of NC does not
influence the surgical outcome.13 We observed
that HA was more frequent and more severe in
patients with MTLE, but no difference in the
severity of hippocampal abnormality could be
associated with the presence or location of NC.
Interestingly, despite fewer patients with ETE
ascertained in this study, the only ETE patient
who had HA had also history of seizures with
jamais-vu and fear in the past, thus indicating a
dual pathology.
Other possibility was that NC, as well as other
environmental factors, such as the occurrence of
earlier febrile seizure, could lead to a hippocampal
damage, which would cause the syndrome of MTLE.
The presence of NC or prior history of febrile seizure
was not related to the finding of HA, suggesting no
cause—consequence relationship between these
two environmental factors and the development
of hippocampal pathology. However, this needs to
be confirmed in larger series.
Finally, there was the possibility that NCwould be
an incidental finding in most patients with epilepsy,
once cysticercosis is endemic in tropical countries.
In our patients, the presence of NC was not neces-
sarily related to the epilepsy syndrome and did notinfluence severity of HA. These observations further
support the role of NC as a co-existent pathology in
patients with partial epilepsy.Acknowledgements
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